Sunway Healthcare Debuts After Malaysia’s Biggest IPO in Nine Years

Sunway Healthcare Holdings Bhd made its stock market debut on March 18 after raising 2.86 billion ringgit in Malaysia’s largest initial public offering in nearly nine years, instantly becoming one of the country’s biggest listed healthcare companies and a high-profile test of investor appetite for the local market.

A landmark listing for Bursa Malaysia

The private hospital operator priced its IPO at 1.45 ringgit a share for both institutional and retail investors, valuing the company at about 16.7 billion ringgit at listing. The float of roughly 1.97 billion shares represents 17.1% of Sunway Healthcare’s enlarged share capital.

The deal is the biggest listing on Bursa Malaysia since petrochemicals producer Lotte Chemical Titan Holding Bhd raised around 3.8 billion ringgit in 2017. For a market that has struggled to attract sizeable new offerings in recent years, the transaction has drawn attention from fund managers, policymakers and healthcare analysts well beyond Kuala Lumpur.

Sunway Healthcare is the hospital and healthcare arm of Sunway Group, the Malaysian conglomerate founded by billionaire Jeffrey Cheah. The unit operates five private hospitals and related healthcare services, and plans to more than double its capacity in the next decade.

“The IPO values Sunway Healthcare at 16.7 billion ringgit, making it the country’s second-largest healthcare company after IHH Healthcare,” the company said in its prospectus released in late February.

Deal structure and use of proceeds

The offering combined new shares issued by Sunway Healthcare with shares sold by existing shareholders Sunway Group and Singapore sovereign wealth fund GIC, which invested in the company in 2021 through its affiliate Greenwood Capital Pte Ltd. The primary tranche is expected to raise about 833.8 million ringgit directly for Sunway Healthcare, with the balance of the 2.86 billion ringgit total coming from secondary share sales.

Sunway Healthcare plans to use about 66.5% of the primary proceeds for capital expenditure, mainly to expand existing hospitals and develop new facilities. The company said it will also redeem Islamic debt and fund working capital and listing expenses.

“We intend to allocate 66.5% of IPO proceeds towards capital expenditure, primarily to expand existing hospitals and develop new facilities,” the company’s management said in briefing materials released alongside the prospectus.

Footprint and financial performance

The listing follows a period of brisk expansion. Sunway Healthcare’s network grew from three hospitals to five between 2022 and 2025, with new facilities opened in Damansara in December 2024 and in Ipoh in April 2025. As of early 2026, the group operated five hospitals with a combined 1,805 licensed beds and more than 700 consultant specialists.

Its flagship Sunway Medical Centre Sunway City in Selangor is one of Southeast Asia’s largest private hospitals, with 848 licensed beds and multiple international accreditations. The facility has been ranked among Malaysia’s top hospitals in global surveys.

Revenue at Sunway Healthcare rose 18.8% year-on-year to 2.2 billion ringgit in the financial year ended 2025, according to the company’s filings. Net profit for the year was 252.2 million ringgit, slightly lower than the 257.5 million ringgit reported in 2024, as administrative and other expenses increased with network expansion. In the fourth quarter of 2025 alone, net profit jumped 43.3% to 112.4 million ringgit on the back of higher patient volumes and stronger operating performance.

Investor demand and cornerstone support

Market demand for the IPO was robust. The Malaysian public offering was oversubscribed 5.57 times, with applications for about 1.51 billion shares against 270 million available to retail investors. The non-Bumiputera portion of the public tranche drew especially strong interest, being oversubscribed more than 10 times, while the Bumiputera public portion was modestly oversubscribed.

On the institutional side, bookbuilding generated orders exceeding 11.7 billion ringgit, according to deal information distributed to investors. A group of 20 cornerstone investors, including the Employees Provident Fund, Lembaga Tabung Haji, Urusharta Jamaah Sdn Bhd and JPMorgan Asset Management’s Singapore unit, took more than half of the institutional shares.

“A total of 20 cornerstone investors subscribed for 52.6% of the institutional offering,” a briefing note to investors said, describing the book as “well covered” at the final price.

Post-listing, Sunway Group remains the controlling shareholder, with an estimated stake of around 69.5% after accounting for a dividend-in-specie distribution by Sunway Berhad that gave its shareholders one Sunway Healthcare share for every 10 Sunway Berhad shares held. GIC, through Greenwood Capital, is expected to hold roughly 7.5% after selling part of its 16% pre-IPO stake but retaining a significant minority position.

A test case for Malaysia’s IPO market

The timing of the IPO comes as Malaysia’s capital market authorities have been trying to revive interest in Bursa Malaysia after several quiet years. Before Sunway Healthcare’s listing, Malaysian IPOs had raised less than US$130 million in 2026, according to market data. Large, domestically focused growth names have been scarce, with the local index dominated by banks, plantations and industrials.

At the same time, Sunway Group has been moving aggressively on other fronts. Sunway Berhad reported record revenue of 7.9 billion ringgit and profit before tax of 1.5 billion ringgit for 2024, and it has tabled an 11 billion ringgit takeover proposal for construction and infrastructure firm IJM Corp Bhd. Analysts say monetising the healthcare arm through a listing gives the group both a visible market valuation for one of its fastest-growing businesses and additional flexibility in managing its balance sheet.

Expansion pipeline—and the policy backdrop

For Sunway Healthcare, the IPO proceeds are intended to underpin an expansion plan that would see its bed capacity rise from about 1,520 at the end of 2024 to more than 3,400 by 2032. New hospitals are planned in Seremban in Negeri Sembilan, Iskandar Puteri in Johor, Putrajaya and additional locations in Penang and Kelantan.

A 401-bed hospital in Iskandar Puteri is one of the centrepieces of that pipeline. The Johor project is positioned to serve both local patients and cross-border demand from Singapore as the two countries deepen cooperation through a special economic zone in the southern corridor.

Independent market research commissioned for the IPO projects strong growth in Malaysia’s private healthcare sector, driven by an ageing population, rising incomes and medical tourism. Sunway Healthcare’s hospitals are integrated into the group’s townships, malls and universities, which analysts say give it access to large, relatively affluent catchment areas and strengthen its positioning in higher-end specialties.

The company has also become a significant player in Malaysia’s medical tourism market. Industry estimates put its share of the country’s medical tourism revenue at about 8% in 2024. Forecasts used in the IPO documents suggest Malaysia’s overall medical tourism revenue could grow at a compound annual rate of around 28% through 2030, though this will depend on global economic conditions and regional competition.

The rapid expansion of private healthcare in Malaysia has drawn policy attention as well as investor interest. Public hospitals remain the backbone of the system, offering heavily subsidized care, but they face persistent resource and staffing constraints. At the same time, individuals with private insurance have complained about rising premiums and tighter coverage terms, prompting calls in Parliament and from consumer groups for Bank Negara Malaysia to scrutinize pricing and benefit designs more closely.

Healthcare professionals and policymakers have also raised concerns that aggressive expansion by well-capitalized private groups could deepen staffing shortages in public facilities. Recruiting and retaining specialists, nurses and allied health workers is a challenge across the system, and private hospitals typically have more scope to offer higher pay and better working conditions.

Valuation debate and what comes next

For now, investors appear focused on growth prospects rather than system-wide pressures. Analysts covering the IPO projected double-digit earnings growth over the next several years, with some forecasting a three-year compound annual growth rate of around 12% in core profit as new hospitals ramp up and existing facilities increase utilization.

Valuation was a central talking point during the marketing process. Based on broker estimates, Sunway Healthcare listed at a premium to domestic peer KPJ Healthcare Bhd and at a level that narrows the gap with regional heavyweight IHH Healthcare Bhd when measured on earnings and enterprise-value-to-EBITDA multiples. Supporters argue the premium is justified by the company’s scale, growth trajectory and integrated model. Others note that hospital projects are capital-intensive and can take years to reach optimal profitability, leaving execution risk if ramp-up is slower than forecast.

The company’s size and liquidity at listing position it as a candidate for inclusion in Malaysia’s benchmark FTSE Bursa Malaysia KLCI index and other thematic and factor-based indices, subject to free float and trading criteria. Any eventual addition could draw further passive fund flows into the stock and increase its influence on the broader market.

How Sunway Healthcare trades in the coming months, and how quickly it can turn new capital into operating beds and profits, will be closely watched by other would-be issuers, domestic pension funds and regulators. For Malaysia’s capital market, the listing offers a rare large-scale test of whether international investors are prepared to pay up for homegrown growth stories. For the country’s healthcare system, it marks another step in the rise of private hospital groups whose fortunes are increasingly tied to both market forces and public policy.